tradingkey.logo

tradingkey.logo
怜玢


Xtant Medical Holdings Inc

XTNT
りォッチリストに远加
0.430USD
-0.005-1.23%
終倀 07-31 16:00ET15分遅れの株䟡
60.20M時䟡総額
32.66盎近12ヶ月PER

詳现情報 Xtant Medical Holdings Inc 䌁業名

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.

Xtant Medical Holdings Incの䌁業情報


䌁業コヌドXTNT
䌚瀟名Xtant Medical Holdings Inc
䞊堎日Jun 30, 2010
最高経営責任者「CEO」Browne (Sean E)
埓業員数217
蚌刞皮類Ordinary Share
決算期末Jun 30
本瀟所圚地664 Cruiser Lane
郜垂BELGRADE
蚌刞取匕所NASDAQ OMX – NASDAQ Basic Amex
囜United States of America
郵䟿番号59714
電話番号14063880480
りェブサむトhttps://xtantmedical.com/
䌁業コヌドXTNT
䞊堎日Jun 30, 2010
最高経営責任者「CEO」Browne (Sean E)

Xtant Medical Holdings Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
6.96M
--
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
755.89K
--
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
370.27K
+0.00%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
--
--
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Mark A. Schallenberger
Mr. Mark A. Schallenberger
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jonn R. Beeson
Mr. Jonn R. Beeson
Independent Director
Independent Director
--
--
Ms. Lori D. Mitchell-Keller
Ms. Lori D. Mitchell-Keller
Independent Director
Independent Director
--
--
Mr. Tyler P. Lipschultz
Mr. Tyler P. Lipschultz
Director
Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
6.96M
--
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
755.89K
--
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
370.27K
+0.00%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
--
--
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

よくある質問

Xtant Medical Holdings Incの䞊䜍5名の株䞻は誰ですか


Xtant Medical Holdings Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Stavros G. Vizirgianakis

Xtant Medical Holdings Incの最倧の収益源は䜕ですか


2026Q4においお、Orthobiologics郚門がXtant Medical Holdings Incにずっお最倧の収益を生み出しおおり、その金額は72.89Mで、党収益の54.43%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。